Answers are grounded in this paper and cite their sources.
Together, these results suggest that PADI2 may function as an important new biomarker for HER2/ERBB2+ tumors and that Cl-amidine represents a new candidate for breast cancer therapy.
No takes yet. Share an insight, caveat, or question.
McElwee et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: